This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Centers for Disease Control and Prevention is seeking public comments on how Americans with chronicpain are successfully treating their symptoms. ” The CDC’s interest in alternative methods of chronicpain management may be of particular significance to many medical cannabis patients.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
The Centers for Disease Control and Prevention is still seeking public comments on how Americans with chronicpain are successfully treating their symptoms. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.
The daily use of cannabis by patients with chronicpain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.
Patients authorized to legally use medical cannabis frequently substitute it in place of benzodiazepines, according to a pair of new studies published this week. According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017.
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Additional information is available from the NORML fact-sheet , ‘Relationship Between Marijuana and Opioids.’
Those suffering from chronicpain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy.
Chronicpain —a condition that affects 50.2 annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronicpain relief have been somewhat hazy…up until now.
The objective of this study was to determine how the use of medical cannabis affects prescribed opioid usage in chronicpainpatients. Healer conducted an online convenience sample survey of patients from three medical cannabis practice sites who had reported using opioids. Peer Reviewed Medical Study .
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.
CBD could “significantly reduce opioid use and improve chronicpain and sleep quality among patients who are currently using opioids for pain management”, according to a new study. Data were collected at three different time points: baseline, 4, and 8 weeks.
Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Endometriosis is a poorly-understood condition causing severe chronicpain and alterations in a woman’s menstrual cycle.
million patients in 2022, a sharp increase from the 3.1 This data aligns with Americans’ rising acceptance of cannabis. While there have been some drops in medical patient registration in states with adult-use (recreational) programs, pandemic-era programs also directly attributed to part of the increase in patient registration.
Cannabis has been used for centuries to manage chronicpain from all sources and, as a recent study highlights, its positive effects extend to migraines. Hybrid strains were most commonly preferred for all types of pain, with “OG Shark” the most preferred strain in the migraine and other headache groups.).
Chronicpainpatients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. An abstract of the research, “No pain, all gain? The data revealed a sustained improvement in the participants’ symptoms. More Research Needed For ChronicPain.
In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronicpain as their primary condition, while in Connecticut 70.4% In Colorado, 78.7% In addition, 87.5%
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.
The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.
Many physicians and health researchers have pointed to cannabis as an alternative to opioids in chronicpainpatients. The new data comes just weeks after researchers at the RAND corporation found that the density of adult-use cannabis dispensaries is linked to greater use of cannabis among young adults in Los Angeles County.
Despite the traumatic brain injury, chronicpain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Journaling can make cannabis use more mindful, deliberate and based on goals, past experiences, and your own personally cultivated data tracking what works best for you. Shutterstock).
They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals.
We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. However, more options have been introduced in the live study as suggested by the patients in the pilot study. S tudy subjects must be willing and ready to substitute opioids with cannabis. “We
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronicpain. billion, servicing nearly 340,000 active patients.
That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronicpain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said.
No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression. Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life.
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronicpain, nausea, seizures, and other medical conditions.
A June 2022 research study conducted in Ontario Canada (where cannabis-based medicine is legal at the federal level), assessed how chronicpainpatients view the use of cannabis-based products for medicinal purposes. Do you think that most patients viewed cannabinoid-based therapeutics as an effective pain remedy?
Goldstein has treated thousands of patients with medical cannabis. She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to ChronicPain. It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research.
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.
Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronicpain. It has been a go-to option for healthcare professionals seeking to manage pain effectively for their patients.
What is the most common qualifying condition reported by medical marijuana patients? Currently and historically the most common qualifying condition reported by medical marijuana patients is chronicpain. See Answer. See Answer.
Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. Chronicpain and “other” are the second highest reasons.
A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronicpain and epilepsy.
The research was published in the journal PLOS One – the name of the study is Frequency of cannabis and illicit opioid use among people who use drugs and report chronicpain: A longitudinal analysis. For the study researchers “included data from people in 2 prospective cohorts. Methods and findings. Conclusions.
The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. There may be a wide variety of causes for this syndrome.
They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. As of January, 2021, PTSD was by far the most-listed qualifying condition in the state, with 57,661 out of 107,371 patients.
In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs. Don’t have time to call? Find Out if You Qualify.
The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronicpain, anxiety, and insomnia. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.
The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS. Improved quality of life.
What is the most common qualifying condition reported by medical marijuana patients? Currently and historically, the most common qualifying condition reported by medical marijuana patients is chronicpain. Boehnke et al.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content